AR and androgen insensitivity syndrome: When analyzing foreskin/labia minora-derived GFs, the APOD assay could again reliably separate male control fibroblasts (group 1) and GFs from AIS individuals harboring an AR-CDS mutation (group 3) (Figure 2C).